Randox Announces Major U.S. Contract with Novation

Newswise — Randox Laboratories has further expanded its market presence in the United States, having been awarded a major supplier agreement with Novation, the leading health care supply chain expertise, analytics and contracting company. The contract means Randox third party quality control products, which are widely considered to be the most accurate in the world, will now be readily available to hospital organizations across the U.S. The new contract with Novation also makes Randox the sole NOVAPLUS® manufacturer of third party controls. NOVAPLUS is the leading private-label brand of products for hospitals and offers organizations supported by Novation the best contract value on items health care organizations purchase the most. Randox is one of the largest manufacturers of third party quality control products in the world. Quality Control is the bedrock of patient blood testing as it helps laboratories assure accuracy in their testing procedures. If errors occur during testing, this can result in misdiagnosis and inappropriate or delayed treatment, which ultimately can be life threatening for the patient. Novation is the leading health care supply chain expertise, analytics and contracting company for the more than 100,000 members of VHA Inc. and UHC, two national health care alliances, Children's Hospital Association, an alliance of the nation's leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Novation develops and manages competitive contracts with more than 800 suppliers. Steven Jordan, Global Business Manager, Randox QC said: ”This agreement with Novation is a strategically important step in Randox’s expansion and we are delighted that our world-leading QC products will now be available for use in many more laboratories across the U.S. I am confident that the quality and range of products available from Randox will make us stand out in the Novation supplier portfolio.” For more information please contact Louise McVicker on +44 (0)28 9445 1016 or email [email protected] or [email protected] ________________________________________About Randox Laboratories Ltd.

Randox is a global market leader within the in vitro diagnostics industry, developing innovative diagnostic solutions for hospitals, clinical, research and molecular labs, food testing, forensic toxicology, veterinary labs and life sciences. With offices and distribution in over 145 countries, Randox offers customers improved efficiency, quality, cost-effectiveness and flexibility. Randox is committed to revolutionising healthcare on a global scale. With over 1000 employees globally, Randox is dedicated to meeting your testing needs. ________________________________________Contact Public Relations for further information on +44 (0) 28 9445 1016

I www.randox.com